| Bioactivity | IRAK inhibitor 4 (trans) is the trans form of IRAK inhibitor 4. IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor. | ||||||||||||
| Name | IRAK inhibitor 4 trans | ||||||||||||
| Formula | C33H35F3N6O3 | ||||||||||||
| Molar Mass | 620.66 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Indazole derivatives as modulators of interleukin-1 receptor-associated kinase. Patent WO 2008030584 A2. |
IRAK inhibitor 4 trans
CAS: F: C33H35F3N6O3 W: 620.66
IRAK inhibitor 4 (trans) is the trans form of IRAK inhibitor 4. IRAK inhibitor 4 is an interleukin-1 receptor associated
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.